Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, Hakim RM.

J Am Soc Nephrol. 2012 Sep;23(9):1551-9. doi: 10.1681/ASN.2012010050. Epub 2012 Aug 16.

PMID:
22904350
2.

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr.

Clin Infect Dis. 2007 Jan 15;44(2):190-6. Epub 2006 Dec 8.

PMID:
17173215
3.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

PMID:
22011388
4.
5.

The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.

McConeghy KW, Bleasdale SC, Rodvold KA.

Clin Infect Dis. 2013 Dec;57(12):1760-5. doi: 10.1093/cid/cit560. Epub 2013 Aug 28. Review.

PMID:
23985343
6.

Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.

Lee S, Kwon KT, Kim HI, Chang HH, Lee JM, Choe PG, Park WB, Kim NJ, Oh MD, Song DY, Kim SW.

Microb Drug Resist. 2014 Dec;20(6):568-74. doi: 10.1089/mdr.2013.0229.

PMID:
25000230
7.

Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.

Wong D, Wong T, Romney M, Leung V.

Ann Clin Microbiol Antimicrob. 2016 Apr 26;15:27. doi: 10.1186/s12941-016-0143-3.

PMID:
27112143
8.

The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.

Blumenthal KG, Shenoy ES, Huang M, Kuhlen JL, Ware WA, Parker RA, Walensky RP.

PLoS One. 2016 Jul 20;11(7):e0159406. doi: 10.1371/journal.pone.0159406. eCollection 2016.

PMID:
27438379
9.

Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.

Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E.

Infect Control Hosp Epidemiol. 2012 Feb;33(2):160-6. doi: 10.1086/663708. Epub 2011 Dec 20.

PMID:
22227985
10.

High-dose cefazolin on consecutive hemodialysis in anuric patients with Staphylococcal bacteremia.

Renaud CJ, Lin X, Subramanian S, Fisher DA.

Hemodial Int. 2011 Jan;15(1):63-8. doi: 10.1111/j.1542-4758.2010.00507.x. Epub 2010 Nov 24.

PMID:
21105995
11.

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.

Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr.

Infect Control Hosp Epidemiol. 2005 Feb;26(2):175-83.

PMID:
15756889
12.

Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.

Shane AL, Hansen NI, Stoll BJ, Bell EF, Sánchez PJ, Shankaran S, Laptook AR, Das A, Walsh MC, Hale EC, Newman NS, Schrag SJ, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Pediatrics. 2012 Apr;129(4):e914-22. doi: 10.1542/peds.2011-0966. Epub 2012 Mar 12.

PMID:
22412036
15.

[Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].

Kızılarslanoğlu MC, Sancak B, Yağcı S, Hasçelik G, Unal S.

Mikrobiyol Bul. 2013 Apr;47(2):199-210. Turkish.

PMID:
23621720
17.

Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.

Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.

Clin Ther. 2013 Jul;35(7):995-1004. doi: 10.1016/j.clinthera.2013.05.018. Epub 2013 Jul 2.

PMID:
23829982
18.

Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.

Kan LP, Lin JC, Chiu SK, Yeh YC, Lin TY, Yang YS, Wang YC, Wang NC, Yeh KM, Chang FY.

J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.

PMID:
23040238
19.

Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.

Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS 2nd.

Antimicrob Agents Chemother. 2014 Sep;58(9):5117-24. doi: 10.1128/AAC.02800-14. Epub 2014 Jun 16.

PMID:
24936596
20.

Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

Laupland KB, Ross T, Gregson DB.

J Infect Dis. 2008 Aug 1;198(3):336-43. doi: 10.1086/589717.

PMID:
18522502

Supplemental Content

Support Center